The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...

The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...

Since Alzheimer's disease affects over 7 million people in the U.S., potentially doubling to 14 million by 2050, earlier ...

The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal brain function.

Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...

The test was cleared for use in people at least 55 years old and who exhibit signs of the disease. It is designed to detect ...

Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...

The FDA has approved the first blood test to detect early Alzheimer’s replacing invasive scans Learn how this game-changing tool could transform diagnosis and treatment ...

Global health stories including rare illnesses, climate change, hypertension, and more, with a focus on little KJ Muldoon's ...